Zurich Cantonal Bank
CPRX

Zurich Cantonal Bank’s Catalyst Pharmaceutical CPRX Stock Holding History

Zurich Cantonal Bank’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-48,643
Closed -$1.14M – 2799
2025
Q4 		$1.14M Buy
+48,643
New +$1.08M ﹤0.01% 1268

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Zurich Cantonal Bank's CPRX Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in Catalyst Pharmaceutical (CPRX) in Q1 2026: 52,974 shares worth $1.31M. The stake represents ﹤0.01% of the portfolio and ranks #1275 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in CPRX as recently as Q3 2025.

Zurich Cantonal Bank first reported a position in CPRX in Q2 2019 and has held it in 27 quarters since. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Zurich Cantonal Bank held 52,974 shares of Catalyst Pharmaceutical worth $1.31M as of Q1 2026.
  • Catalyst Pharmaceutical was a new Zurich Cantonal Bank position in Q1 2026.
  • Catalyst Pharmaceutical made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #1275 holding.
  • Zurich Cantonal Bank first reported a position in Catalyst Pharmaceutical in Q2 2019 and has held it in 27 quarters since.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.